Clinicopathological features of primary splenic follicular lymphoma

Ann Hematol. 2017 Dec;96(12):2063-2070. doi: 10.1007/s00277-017-3139-y. Epub 2017 Oct 3.

Abstract

Follicular lymphoma (FL) is a low-grade lymphoma that is usually characterized by generalized lymphadenopathy. Extranodal invasion by FL generally involves the bone marrow, skin, and duodenum; splenic infiltration often occurs in the advanced stages. However, primary splenic FL is very rare. Hence, few studies have been performed on splenic FL, and its clinicopathological features have not been established. This study aimed to investigate the clinicopathological features of primary splenic FL, as compared to nodal FL. We analyzed 17 patients diagnosed with primary splenic FL and 153 control patients with systemic FL. Hepatitis C virus (HCV)-positive status was significantly more common in patients with splenic FL than in the control patients (p = 0.02). Ann Arbor stage III or IV (p = 0.0003) and high-risk FLIPI (Follicular Lymphoma International Prognostic Index) (p = 0.03) were significantly less common in patients with splenic FL than in the control patients; however, the overall and progression-free survival curves were not significantly different between the groups. Among the 17 patients with splenic FL, the progression-free survival was significantly worse in patients who underwent splenectomy without receiving postoperative chemotherapy than in those who did (p = 0.03). These results suggest that primary splenic FL should be considered different from systemic FL; accordingly, its management should also be conducted differently.

Keywords: Clinicopathological characteristics; Follicular lymphoma; Hepatitis C virus; Prognosis; Splenic lymphoma.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Aged, 80 and over
  • Disease-Free Survival
  • Female
  • Hepacivirus*
  • Hepatitis C* / blood
  • Hepatitis C* / mortality
  • Hepatitis C* / therapy
  • Humans
  • Lymphoma, Follicular* / blood
  • Lymphoma, Follicular* / mortality
  • Lymphoma, Follicular* / therapy
  • Lymphoma, Follicular* / virology
  • Male
  • Middle Aged
  • Splenectomy
  • Splenic Neoplasms* / blood
  • Splenic Neoplasms* / mortality
  • Splenic Neoplasms* / therapy
  • Splenic Neoplasms* / virology
  • Survival Rate